ScotRail charity partnership extended

The ScotRail Alliance has announced their continuing support for MND Scotland for a further two years!

The partnership between MND Scotland and Scotland’s railway, which was set to end in March 2020, has been an unprecedented success, with customers and staff raising a whopping £255,000 since 2017, smashing their target of £150,000.

The ScotRail Alliance smashed their original target of £150,000 and has gone above and beyond expectations. The huge sum has been raised through staff fundraising, customer donations and gifts in kind, such as advertising on trains and in stations.

Now the partnership will continue until 2022, allowing us to continue our “journey to a cure” with the ScotRail Alliance.

Just last month we announced a £1.5million investment into the UK’s biggest MND drug trial. Funds raised through the ScotRail Alliance have contributed to this monumental step towards finding a cure for the disease and giving people living with MND hope.

Alex Hynes, Managing Director of Scotland’s Railway, said: “I am absolutely delighted that we will be continuing our work with MND Scotland over the next two years.

“MND Scotland is an incredible charity doing extraordinary work right across our country, and the recent drug trials show just how valuable our fundraising efforts can be.

“I’m really proud of our people and customers who have helped to raise more than £250,000 for this great cause so far, and I’m looking forward to raising even more over the next two years.”

Iain McWhirter, MND Scotland’s Head of Fundraising, said: “We are delighted that the ScotRail Alliance are going to be joining us on our journey to a cure for another two years.

“We have been blown away by the support we have received, from staff jumping out planes and organising coffee mornings, to customers donating across the country, and advertising which has helped raise awareness with commuters throughout Scotland.

“Thanks to the generosity of supporters like this we have been able to fund the most comprehensive MND drug trial in a generation. This trial will be open to almost every person with MND in Scotland and we hope will lead to finding effective treatments and ultimately a cure for MND.”